FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marina Núñez

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Marina Núñez; Celia Miralles; Miguel Angel Berdún; Elena Losada; Koldo Aguirrebengoa; Antonio Ocampo; Piedad Arazo; Manuel Cervantes; Ignacio de Los Santos; Isabel San Joaquín; Santiago Echeverría; María José Galindo; Victor Asensi; Pablo Barreiro; Julio Sola; Juan José Hernandez-Burruezo; Josep Maria Guardiola; Miriam Romero; Javier García-Samaniego; Vincent Soriano
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
Marina Núñez; Ana Mariño; Angel Mariño; Celia Miralles; Miguel Angel Berdún; Julio Sola; Juan José Hernandez-Burruezo; María José Galindo; Pablo Barreiro; Luz Martin-Carbonero; Vincent Soriano
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.
Ivana Maida; Vincent Soriano; Pablo Barreiro; Pablo Rivas; Pablo Labarga; Marina Núñez
Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marina Núñez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Marina Núñez; Celia Miralles; Miguel Angel Berdún; Elena Losada; Koldo Aguirrebengoa; Antonio Ocampo; Piedad Arazo; Manuel Cervantes; Ignacio de Los Santos; Isabel San Joaquín; Santiago Echeverría; María José Galindo; Victor Asensi; Pablo Barreiro; Julio Sola; Juan José Hernandez-Burruezo; Josep Maria Guardiola; Miriam Romero; Javier García-Samaniego; Vincent Soriano
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
AIDS research and human retroviruses 2007;23(8):972-82.
2007: Marina Núñez; Ana Mariño; Angel Mariño; Celia Miralles; Miguel Angel Berdún; Julio Sola; Juan José Hernandez-Burruezo; María José Galindo; Pablo Barreiro; Luz Martin-Carbonero; Vincent Soriano
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):439-44.
2007: Ivana Maida; Vincent Soriano; Pablo Barreiro; Pablo Rivas; Pablo Labarga; Marina Núñez
Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases.
AIDS research and human retroviruses 2007;23(6):801-4.
2007: Luz Martín-Carbonero; Pablo Barreiro; G Jiménez-Galán; R García-Berriguete; Marina Núñez; Pilar Ríos; Juan González-Lahoz; Vincent Soriano
Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
Journal of viral hepatitis 2007;14(6):392-5.
2007: Belen Ramos; Marina Núñez; Ana Rendón; Miguel Angel Berdún; Elena Losada; I Santos; Santiago Echevarría; Antonio Ocampo; Celia Miralles; Piedad Arazo; Pablo Barreiro; Miriam Romero; Pablo Labarga; Josep Maria Guardiola; Javier Garcia-Samaniego; Vincent Soriano
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
Journal of viral hepatitis 2007;14(6):387-91.
2007: Belen Ramos; Marina Núñez; Luz Martín-Carbonero; Julie Sheldon; Pilar Rios; Pablo Labarga; Miriam Romero; Pablo Barreiro; Javier García-Samaniego; Vincent Soriano
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2007;44(5):557-61.
2007: Belen Ramos; Marina Núñez; Carlos Toro; Julie Sheldon; Javier García-Samaniego; Pilar Ríos; Vincent Soriano
Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients.
The Journal of infection 2007;54(2):173-9.
2006: Marina Núñez; Vincent Soriano; Mariola López; Celia Ballesteros; Almudena Cascajero; Juan González-Lahoz; José Benito
Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(9):1209-12.
2006: Pablo Barreiro; Jorge del Romero; Manuel Leal; Victoria Hernando; Román Asencio; Carmen de Mendoza; Pablo Labarga; Marina Núñez; José Tomás Ramos; Juan González-Lahoz; Vincent Soriano
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2006;43(3):324-6.
2006: Ivana Maida; Vincent Soriano; Carol Castellares; Belen Ramos; Giovanni Sotgiu; Luz Martin-Carbonero; Pablo Barreiro; Pablo Rivas; Juan González-Lahoz; Marina Núñez
Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity.
HIV clinical trials 2006;7(5):246-50.
2006: Marina Núñez; Belen Ramos; Beatriz Díaz-Pollán; Nuria Camino; Luz Martín-Carbonero; Pablo Barreiro; Juan González-Lahoz; Vincent Soriano
Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.
AIDS research and human retroviruses 2006;22(9):842-8.
2006: Ivana Maida; Marina Núñez; Maria José Ríos; Luz Martín-Carbonero; Giovanni Sotgiu; Carlos Toro; Pablo Rivas; Pablo Barreiro; Maria Stella Mura; Sergio Babudieri; Javier Garcia-Samaniego; Juan González-Lahoz; Vincent Soriano
Severe liver disease associated with prolonged exposure to antiretroviral drugs.
Journal of acquired immune deficiency syndromes (1999) 2006;42(2):177-82.
2006: Pablo Barreiro; Luz Martín-Carbonero; Marina Núñez; Pablo Rivas; Adolfo Morente; Nuria Simarro; Pablo Labarga; Juan González-Lahoz; Vincent Soriano
Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(7):1032-9.
2006: Ivana Maida; Sergio Babudieri; Cinzia Selva; Gianpiero D'Offizi; Luisa Fenu; Giuliana Solinas; Pasquale Narciso; Maria Stella Mura; Marina Núñez
Liver enzyme elevation in hepatitis C virus (HCV)-HIV-coinfected patients prior to and after initiating HAART: role of HCV genotypes.
AIDS research and human retroviruses 2006;22(2):139-43.
2005: Ivana Maida; Vincent Soriano; Belen Ramos; Pilar Ríos; Juan González-Lahoz; Marina Núñez
Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center.
HIV clinical trials 2005;6(6):329-36.
2005: Ana Rendón; Marina Núñez; Inmaculada Jiménez-Nácher; Daniel González de Requena; Juan González-Lahoz; Vincent Soriano
Clinical benefit of interventions driven by therapeutic drug monitoring.
HIV medicine 2005;6(5):360-5.
2005: Ana Rendón; Marina Núñez; Miriam Romero; Pablo Barreiro; Luz Martín-Carbonero; Javier García-Samaniego; Inmaculada Jiménez-Nácher; Juan González-Lahoz; Vincent Soriano
Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2005;39(4):401-5.
2005: Marina Núñez; Vincent Soriano
Current concepts in the management and treatment of hepatitis C in HIV-infected patients.
Annals of hepatology 2005;4(3):151-60.
2005: Ivana Maida; Marina Núñez; Juan González-Lahoz; Vincent Soriano
Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation?
AIDS research and human retroviruses 2005;21(7):599-601.
2005: Marina Núñez; Vincent Soriano
Management of patients co-infected with hepatitis B virus and HIV.
The Lancet infectious diseases 2005;5(6):374-82.
2005: Ana Barrios; Ana Rendón; Eugenia Negredo; Pablo Barreiro; Teresa Garcia-Benayas; Pablo Labarga; Jesús Santos; Pere Domingo; Matilde Sánchez Conde; Ivana Maida; Luz Martín-Carbonero; Marina Núñez; Francisco Blanco; Bonaventura Clotet; Maria Antonia Sambeat; Paloma Gil; Juan Gonzalez-Lahoz; David Cooper; Vincent Soriano
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine.
AIDS (London, England) 2005;19(6):569-75.
2005: Marina Núñez
Highlights from the 1st International Workshop on HIV and Hepatitis Co-infection.
HIV clinical trials 2005;6(2):118-25.
2005: Marina Núñez; Ivana Maida; Sergio Babudieri; Luisa Fenu; Nuria Camino; Juan González-Lahoz; Maria Stella Mura; Vincent Soriano
Hepatitis C viremia in HIV/HCV-coinfected patients: lower levels in presence of chronic hepatitis B.
HIV clinical trials 2005;6(2):103-6.
2005: Julie Sheldon; Nuria Camino; Berta Rodés; Angeline Bartholomeusz; Michael Kuiper; Frank Tacke; Marina Núñez; Stefan Mauss; Thomas Lutz; Gerd Klausen; Stephen Locarnini; Vincent Soriano
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
Antiviral therapy 2005;10(6):727-34.
2005: Vincent Soriano; Marina Núñez; Matilde Sánchez Conde; Pablo Barreiro; Javier García-Samaniego; Luz Martín-Carbonero; Miriam Romero; Juan González-Lahoz
Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
Antiviral therapy 2005;10(1):167-70.
2005: Marina Núñez; Vincent Soriano
Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(1):53-66.
2004: Vincent Soriano; Ivana Maida; Marina Núñez; Javier García-Samaniego; Pablo Barreiro; Luz Martín-Carbonero; Juan González-Lahoz
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies.
Antiviral therapy 2004;9(6):987-92.
2004: Marina Núñez; Javier García-Samaniego; Vicente Soriano
[Advances in the diagnosis and treatment of the infection by the hepatitis B virus].
Enfermedades infecciosas y microbiología clínica 2004;22(9):539-49.
2004: Vincent Soriano; Marina Núñez; Nuria Camino; Ivana Maida; Pablo Barreiro; Miriam Romero; Luz Martin-Carbonero; Javier Garcia-Samaniego; Juan González-Lahoz
Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Antiviral therapy 2004;9(4):505-9.
2004: Daniel González-Requena; Marina Núñez; Inmaculada Jiménez-Nacher; Juan González-Lahoz; Vincent Soriano
Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection.
AIDS research and human retroviruses 2004;20(7):698-700.
2004: Pablo Barreiro; Arturo Corbatón; Marina Núñez; Juan González-Lahoz; Vincent Soriano
Tolerance of didanosine as enteric-coated capsules versus buffered tablets.
AIDS patient care and STDs 2004;18(6):329-31.
2004: Vincent Soriano; Mayte Pérez-Olmeda; Pilar Ríos; Marina Núñez; Javier García-Samaniego; Juan González-Lahoz
Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients.
AIDS research and human retroviruses 2004;20(4):351-3.
2004: Carmen de Mendoza; Ellen Paxinos; Pablo Barreiro; Nuria Camino; Marina Núñez; Vincent Soriano
Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations.
Journal of clinical microbiology 2004;42(2):862-6.
2003: Marina Núñez; Massimo Puoti; Nuria Camino; Vincent Soriano
Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(12):1678-85.
2003: Mayte Pérez-Olmeda; Vincent Soriano; Victor Asensi; Dolores Morales; Miriam Romero; Anna Ochoa; Fausto Sánchez-Montero; Miguel Santin; Josep Guardiola; Jesús Blanch; Marina Núñez; Inmaculada Jiménez-Nácher; Javier García-Samaniego
Treatment of chronic hepatitis C in HIV-infected patients with interferon alpha-2b plus ribavirin.
AIDS research and human retroviruses 2003;19(12):1083-9.
2003: Pablo Barreiro; Carmen de Mendoza; Nuria Camino; Teresa García-Benayas; Francisco Blanco; Marina Núñez; Juan González-Lahoz; Vincent Soriano
Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy.
HIV clinical trials 2003;4(6):361-71.
2003: Ana Rendón; Marina Núñez; Daniel González-Requena; Inmaculada Jiménez-Nácher; Juan González-Lahoz; Vincent Soriano
Diarrhea related to lopinavir is most often mild and not related to plasma drug levels.
Journal of acquired immune deficiency syndromes (1999) 2003;34(2):247.
2003: Mayte Pérez-Olmeda; Marina Núñez; Javier García-Samaniego; Pilar Ríos; Juan González-Lahoz; Vincent Soriano
Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.
AIDS research and human retroviruses 2003;19(8):657-9.
2003: Mayte Pérez-Olmeda; Marina Núñez; Miriam Romero; Juan González; Angeles Castro; José R Arribas; José Pedreira; Pablo Barreiro; Javier García-Samaniego; Luz Martín-Carbonero; Inmaculada Jiménez-Nácher; Vincent Soriano
Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
AIDS (London, England) 2003;17(7):1023-8.
2003: Marina Núñez; Román Asencio; M Eulalia Valencia; Manuel Leal; Juan González-Lahoz; Vincent Soriano
Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy.
AIDS research and human retroviruses 2003;19(5):363-8.
2003: Vincent Soriano; Mayte Pérez-Olmeda; Pilar Ríos; Marina Núñez; Javier García-Samaniego; Juan González-Lahoz
Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes?
Journal of acquired immune deficiency syndromes (1999) 2003;32(4):465-6.
2003: Nuria Camino; Marina Núñez; Francisco Blanco; Daniel González-Requena; Juan González-Lahoz; Vincent Soriano
Indinavir-induced thrombocytopenia.
AIDS patient care and STDs 2003;17(3):103-4.
2003: Marina Núñez; Daniel González-Requena; Juan González-Lahoz; Vincent Soriano
Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients.
AIDS research and human retroviruses 2003;19(3):187-8.
2003: Luz Martín-Carbonero; Marina Núñez; Juan González-Lahoz; Vincent Soriano
Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.
HIV clinical trials 2003;4(2):115-20.
2002: Pablo Barreiro; Nuria Camino; Carmen de Mendoza; Luisa Valer; Marina Núñez; Luz Martín-Carbonero; Juan González-Lahoz; Vincent Soriano
Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors.
International journal of antimicrobial agents 2002;20(6):438-43.
2002: Marina Núñez; Mayte Pérez-Olmeda; Beatriz Díaz; Pilar Ríos; Juan González-Lahoz; Vincent Soriano
Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
AIDS (London, England) 2002;16(17):2352-4.
2002: Daniel González De Requena; Marina Núñez; Oscar Gallego; Inmaculada Jiménez-Nácher; Juan González-Lahoz; Vincent Soriano
Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?
HIV clinical trials 2002;3(6):463-7.
2002: Marina Núñez; Pilar Ríos; Mayte Pérez-Olmeda; Vincent Soriano
Lack of 'occult' hepatitis B virus infection in HIV-infected patients.
AIDS (London, England) 2002;16(15):2099-101.
2002: Luz Martín-Carbonero; Marina Núñez; Pilar Ríos; Mayte Pérez-Olmeda; Juan González-Lahoz; Vincent Soriano
Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.
AIDS (London, England) 2002;16(10):1423-5.
2002: Carmen de Mendoza; Luz Martín-Carbonero; Pablo Barreiro; Beatriz Diaz; Eulalia Valencia; Inmaculada Jiménez-Nácher; Oscar Gallego; Marina Núñez; Juan González-Lahoz; Vincent Soriano
Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families.
HIV clinical trials 2002;3(4):304-9.
2002: Marina Núñez; Pilar Ríos; Luz Martín-Carbonero; Mayte Pérez-Olmeda; Juan González-Lahoz; Vincent Soriano
Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;30(1):65-8.
2002: Marina Núñez; Vincent Soriano; Luz Martín-Carbonero; Ana Barrios; Pablo Barreiro; Francisco Blanco; Teresa García-Benayas; Juan González-Lahoz
SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals.
HIV clinical trials 2002;3(3):186-94.
2002: Mayte Pérez-Olmeda; Pilar Ríos; Marina Núñez; Javier García-Samaniego; Miriam Romero; Vincent Soriano
Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment.
AIDS (London, England) 2002;16(3):493-5.
2002: Daniel González de Requena; Marina Núñez; Inmaculada Jiménez-Nácher; Vincent Soriano
Liver toxicity caused by nevirapine.
AIDS (London, England) 2002;16(2):290-1.
2001: Marina Núñez; Daniel González de Requena; L Gallego; Inmaculada Jiménez-Nácher; Juan González-Lahoz; Vincent Soriano
Higher efavirenz plasma levels correlate with development of insomnia.
Journal of acquired immune deficiency syndromes (1999) 2001;28(4):399-400.
2001: Raquel Lana; Marina Núñez; Juan L Mendoza; Vicente Soriano
[Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy].
Medicina clínica 2001;117(16):607-10.
2001: Marina Núñez; Raquel Lana; Juan L Mendoza; Luz Martín-Carbonero; Vincent Soriano
Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2001;27(5):426-31.
2001: Marina Núñez; Rafael Rodríguez-Rosado; Vincent Soriano
Intensification of antiretroviral therapy.
AIDS research and human retroviruses 2001;17(6):499-506.
2000: Marina Núñez; Vincent Soriano
Salvage therapy for HIV infection: when and how.
AIDS patient care and STDs 2000;14(9):465-76.
2000: Marina Núñez; A Machuca; Vincent Soriano; D Podzamczer; Juan González-Lahoz
Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.
AIDS (London, England) 2000;14(8):913-9.